The management of competing stakeholders has emerged as an important topic for formulating business strategies. This is especially the case in the complicated business environment like the healthcare IT (Information Technology) industries. This paper proposes a methodology to formulate business strategies based on stakeholders' demands. Our methodology begins with the understanding of stakeholders' demands. This understanding is particularly useful for businesses with conflicting stakeholders. Our methodology consists of four phases: current business analysis, strategy development, strategy evaluation, and strategy implementation. Power, legitimacy, urgency, interdependence, cooperation, and conflict are used as stakeholders related variables. Strategic alternatives are derived on the basis of stakeholders' demands. Resolution, replacement, integration, reaggregation, and balance guidelines are employed for this derivation. Strategic alternatives are then evaluated according to a business social performance index. In order to demonstrate the practical usefulness of our methodology, three business cases for the Korean healthcare IT industry are illustrated. The case results imply that our methodology is useful for strategy formulation, especially in the case of competing business stakeholders.
Introduction
Corporate management evolves depending on new requirements and challenges. Business strategies need to be in perfect alignment with ever-changing corporate goals. These goals are increasingly dependent on business environments. Once a business has reconceived its own contours, it is ready to face up to a new kind of environment. The challenges in formulating the strategies are readily apparent.
Freeman 9 initiated a stakeholder theory and thus enabled corporations to understand their environments; stakeholders were defined as groups or individuals who can affect or be affected by organizations with their managerial behaviors. Organization theorists have explored the role of the stakeholders in corporate management since Freeman's original work. Recently, they have shifted the goal of corporations from shareholder's wealth creation to stakeholder's balance which pursues multiple objectives with different interests. 17 They compared shareholder corporations with stakeholder corporations in terms of their attributes such as goal, governance structures and key processes, performance metrics, and stakeholders' salience/influence. Wheeler and Sillanpaa 26 illustrated the business cases of successful stakeholders' corporations such as Wal-Mart (US), Tesco (UK), IBM (US), and The Body Shop (UK). It is not a trivial task to formulate business strategies from the stakeholders' perspectives. Typically, stakeholders show diverse business interests. The goals of the stakeholders may be in conflict with each other; they may threaten business organizations. The conflicts arising among the stakeholders, if well managed, can act as a synergy factor leading to a better cooperation and participation of the stakeholders. It is thus important to deal with stakeholders' demands. It is important to note that stakeholders' demands are considered for strategy formulation. Doing so increases the corporate collective strength and everyone's chance of winning.
The healthcare IT (Information Technology) industry shows typical examples of conflicting interests and complicated interactions among stakeholders. In Korea, this industry's businesses can be categorized into five groups; (i) hospital (clinic) information systems (HIS) including electronic medical records (EMR), order communication systems (OCS), and pharmacy information systems (PIS), (ii) picture archiving and communication systems (PACS), (iii) medical data connectivity including medical EDI (electronic data interchange) and electronic prescriptions, (iv) healthcare EC (electronic commerce) (e.g. business to business (B2B), business to customer (B2C), cyber hospital, and drug electronic procurements), and (v) medical electronic equipments. This industry finds a variety of conflicting interests among stakeholders such as patients, physicians, general hospitals, hospitals, clinics, dental clinics, pharmacies, the government, and medical insurance corporations. Managers face significant regulations by the government and medical insurance corporations. In this highly competitive healthcare environment, the survival of businesses may depend on how well they manage heterogeneous stakeholders. 20 The primary objectives of this paper are to propose a methodology for formulating business strategies on the basis of stakeholders' demands and to demonstrate its usefulness through the case of a real-life healthcare IT business. This stakeholders' approach will be able to enhance both business performance and business ethical goals. Furthermore, we develop a method for evaluating strategic alternatives using stakeholders, 5, 31 how to define and use stakeholders related variables, 11, 21 how to balance the competing demands of various stakeholders, 29 and how to measure business performance with stakeholders related variables. 1, 4, 24 The following is the review for the studies in the above main research areas.
Identification of key stakeholders:
Freeman 10 identified the stakeholders such as the government, political groups, shareholders, the financial community, activist groups, consumers, consumer advocacy groups, unions, employees, trade associations, competitors, and suppliers. Morgan In sum, the findings from the above studies can be categorized as follows. First, business performance may include both BFP and business social performance (BSP). Second, stakeholder's relationship affects business performance. Third, improving the relationship between SBU and its stakeholders can enhance BSP.
Business Strategy Formulation Methodology
Strategies may be categorized according to three distinct levels: corporate strategy, business strategy, and functional strategy. Some SBUs have homogeneous services or products that are independent from the other SBUs. Business strategy, a subset of corporate strategy, is defined as the basis upon which an organization achieves a competitive advantage; it has a direct and significant effect on business performance. 32 Business strategy can help business leaders achieve business goals. 5 we adopt a stakeholder's perspective. Stakeholder demands play a vital role because nowadays most businesses are confronted with powerful stakeholders having different goals. For example, B2B sites may be confronted with obstinate resistance from existing off-line channel suppliers. However, buyers and suppliers can reduce their cost via electronic procurements. Therefore, these sites need to formulate business strategies based on the conflicting demands of different stakeholders.
As depicted in Fig. 1 , our methodology consists of four major phases: current business analysis, strategy development, strategy evaluation, and strategy implementation. The current business analysis phase defines and analyzes SBUs and related stakeholders. The emphasis is on the analysis of stakeholders' demands. The strategy development phase offers strategic alternatives according to five guidelines: resolution, replacement, integration, reaggregation, and balance. Then, it filters these alternatives through core competences and weaknesses. In the strategy evaluation phase, the alternatives are evaluated by the stakeholder relationship improvement index (SRII). SRII estimates how the strategy can improve the relationships between a business organization and its stakeholders. The strategy implementation phase makes a detailed action plan for a final strategy and implements it. The performance of this new strategy can be monitored continuously after implementation; the strategy may be adjusted if it is not satisfactory.
Korean Healthcare IT Business Cases
To demonstrate its practical applicability, our methodology has been applied to three Korean healthcare IT cases such as medical EDI business in 2000, electronic prescription business, and tax receipt for cash business. For a clear presentation, The medical EDI business highlights very competitive and conflicting stakeholders like those in the medical professions, medical insurance industry, and pharmaceutical industry. In particular, because of the enforcement of the rule on the separation of medical practices and drug dispensation in July 2000, the conflict among these groups caused tremendous disorder in the Korean society.
Medical EDI service enables the electronic interchange and delivery of medical insurance documents (e.g. medical insurance claims including treatments, screening results of claims, and financial results) between medical groups (e.g. hospitals, clinics, dental clinics, and oriental clinics) and pharmacies, and medical insurance corporations (e.g. health insurance corporations, industrial accident compensation insurance corporations, and automobile insurance corporations). Before this EDI service, papers and diskettes were the primary delivery methods.
The following is the market scale of the medical EDI business in 1999: (i) about 240 million medical documents (e.g. papers, diskettes, and EDI) were exchanged per year, (ii) about 57 thousand institutions were candidates for subscribing EDI service, and (iii) the total amount of market was about 30 billion Won (Korean monetary standard unit). K Corporation is the largest and the most sophisticated communication network company in Korea. It leads the nation's telecommunication industry for over 100 years. It puts forward a new vision of "The Value Networking Company" in order to emerge as one of the world's leading telecommunication companies in the 21st century. It has provided high-speed Internet services such as asymmetric digital subscriber line (ADSL), very high data rate digital subscriber line (VDSL), and wireless Internet.
In particular, since 1996, K Corporation have had exclusive rights to provide EDI service for 10 years in the medical insurance fields and began an example of providing EDI service to 100 customers (clinics) in the Metropolitan area. Standard document format and medical code were necessary to convert complex paper data to standard EDI data. In 1997, the Korean Government officially announced the detailed rules on how to use the medical EDI. Accordingly, K Corporation could extend service areas to the whole country; the service domain ranged from clinics to hospitals, dental clinics, pharmacies, and oriental clinics.
The Korean medical EDI business' circumstances during 1999-2000 were as follows. First, although Korean society would decide to enforce the new healthcare rule for the separation of medical practice and drug dispensation since July 2000, the conflicts among government, medical groups, pharmaceutical groups, insurance corporation groups, and society organizations caused serious debate on how to enforce the rule. Medical and pharmaceutical processes changed significantly; their EDI formats and application software (S/W) for HIS was also unavoidably changed and this change caused serious confusion. Stakeholders, in particular, required different EDI standard format and this format changed many times until July 2000. If the rule was enforced, the volume of EDI data would increase dramatically; accordingly, the market volume of EDI business would increase significantly.
Second, the number of subscribing institutions and the corresponding business sales were not satisfactory to K Corporation. Despite of the convenience and speed, most institutions were reluctant to change their delivery methods to EDI service because they feared the exposure of detailed treatment data to medical insurance corporations or government. Third, the EDI services needed to be enhanced into web-based service. K Corporation began to provide ADSL service for the institutions. Thus, they required web-based EDI interfaces.
In view of this EDI circumstance, three strategic problems are noted: (i) the lack of balance in the management of stakeholders, (ii) insufficient marketing results, and (iii) the lack of counterplan to the enforcement of the new rule. Our methodology has been applied to formulate strategies for this EDI business in 2000 for K Corporation. For this application, we interviewed one director and 10 managers who formulated EDI business strategies or managed this business for K Corporation in 2000. This application will be illustrated in detail from now on.
Current Business Analysis
The purpose of this phase is to analyze the current business environment and related key stakeholders. First, we define the SBU and related stakeholders. Our SBU is thus the medical EDI business in K Corporation. Business-related key stakeholders are identified as shown in Table 1 . Here, we adopt Donaldson and Preston's 8 major stakeholder group categories. Next, the SBU is analyzed, i.e. it searches for business-related strategic problems, BFP, and core competences and weaknesses of the corporate resources. The objective of the current business strategic problem analysis is to find the critical strategic problems for the success of the business and to find how much their results are affected by related stakeholders. In order to measure BFP, we employ ROS (net income before taxes/sales) and growth in sales (i.e. rate of increase compared to last year's sales).
Grant 12 classified corporate resources into six major categories: financial, physical, human, technological, reputation, and organizational. By using these categories, we can find the corresponding core competences and weaknesses. In sum, the results of strategic problem, BFP, core competence and weakness can be presented in the current business analysis report, as shown in Next, stakeholders' demands are identified for each stakeholder. Managers need to look at these demands from a long-term perspective and endeavor to negotiate or mediate them. The importance of these demands (i.e. demand criticality) is also determined. Demand criticality is defined as the degree to the urgency and managerial sensitivity of the demand. All variables are measured via a 5 point Likert's scale ranging from "strongly disagree (+1)" to "strongly agree (+5)". We refer Agle et al. 1 
Strategy Development
The aim of this phase is to find new strategic alternatives in the light of stakeholders' demands. Typically, it is complex to find strategic alternatives in the consideration of all demands. It would be helpful to select more critical demands and use them for generating strategic alternatives. Although primary stakeholders' demands are more critical if business organizations ignore them, secondary stakeholders' demands can sometimes also cause significant damage to businesses. 5 Therefore, these demands are considered as a two-step approach (first, primary stakeholders in isolation, and then both primary and secondary stakeholders).
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In August 1999, there were 56,871 total institutions (possible subscribers).
( ) denotes the ratio compared with total possible subscribers.
Accordingly, we need to rank stakeholders' demands according to their importance and demand criticality. Important demands may be selected as follows.
If Rank(φ(i, j) ) ≤ k, then Select; k: number of important demands which strategy managers may decide.
In our case, managers decided on ten important demands (k = 10). Equal weights were assumed for the sake of simplicity (w 1 = w 2 = w 3 = 1 3 ). These weights may be determined by the experts.
Next, we can formulate strategies for the above chosen 10 demands. Two alternatives are possible. The first (Alternative 1) is generated in view of primary demands; the second (Alternative 2) is generated in view of both primary and secondary demands. Referring to the literature of organizational responses to stakeholders' demands, 3,25,29 we employ five guidelines (i.e. resolution, replacement, integration, reaggregation, and balance) for generating strategic alternatives. Table 3 compares these guidelines. 
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The resolution guideline applies for demands which cause conflicts with other demands; it may provide the business opportunities when conflicts are resolved. Negotiations and mediations are effective for resolving conflicts. 3, 18 For example, for the S/W firms' demand to ally strategically with K Corporation for joint S/W upgrade and marketing and the government's demand to manage the conflicts between medical institutions and S/W firms, we may consider a strategic alternative to ally with S/W firms to establish an executive team for S/W upgrading and marketing with EDI service and HIS. This alternative resolves the conflicts among their demands because K Corporation can control S/W firms through a joint team.
a
The replacement guideline improves the contents of stakeholders' demands in order to better accommodate the business prosperity. For example, let us consider the government's demand to prepare a new EDI S/W version suitable for the rule before July 2000. Because the rule will be changed many times according to the negotiation among related stakeholders, the better alternative would be to delay new S/W version until the rule is settled.
The integration guideline integrates similar demands. We may adopt stakeholder learning dialogues 7 Finally, stakeholders need to strike a balance among their demands. For example, let us consider the health insurance corporation's demand that new EDI standard format for insurance claim should include prescription details for cross-checking from hospitals to pharmacies. This option could be biased for the benefit of the insurance corporations in isolation. It would be a good alternative to establish the committee for EDI standard format decision including the government, insurance groups, medical groups, and pharmacies.
The resulting two alternatives (Alternatives 1 and 2) can be filtered in view of the core competences and weaknesses. If they are to exploit core competences of corporate resources or strengthen competitive advantages for future resources, the alternatives are sharpened toward this direction. In contrast, if they tend to weaken a Before the year 2000, EDI service had spreaded through the medical S/W firm's HIS in parallel with K Corporation's HIS for clinic because EDI S/W module was embedded in HIS. Therefore, medical S/W firms began passively to adopt EDI service marketing because they had some doubts that K Corporation would have strategies to branch out its HIS market in the future. Thus, K Corporation changed its perspectives of medical S/W firms by converting obstacles of its business to a win-win situation and being an essential partner. the corporate resources, the opposite is the case. Appendix 4 summarizes the final strategic alternatives after this filtering.
Strategy Evaluation
This phase evaluates strategic alternatives. Business performance measures are either financial (e.g. BFP) or social (e.g. BSP). Financial measures do not seem to be applicable for stakeholders. It is difficult to predict future financial performance in the case of new strategy. Unlike financial measures, social measures appear to be relatively convenient. Here, we propose a particular social measure called SRI (stakeholder relationship index).
SRI consists of two major components: stakeholder's importance and stakeholder's relationship. Typically, the stakeholder importance has been determined in terms of power 6, 11, 15 or salience. 21 The stakeholder importance may be the combination of power, legitimacy, and urgency. Behind this measurement lies the implicit assumption that any stakeholder's importance does not change; i.e. it does not depend upon our business strategy. Stakeholder's relationship was measured in terms of interdependence, 11,27 cooperation and threat, 10 the relationship qualities among internal, external, and distal stakeholders, 31 or the KLD index. 4 The stakeholder's relationship can consist of absolute magnitude and stakeholder potential. We employ interdependence for absolute magnitude, and cooperation and conflict for stakeholder's potential. Now, we can calculate SRII which measures how a new strategy can improve SRI. SRII may be computed as SRII = SRI (new) − SRI (current). SRI (t) denotes the SRI when a particular strategy t is adopted. SRI (t) can be computed as follows.
where RL(i, t): stakeholder relationship between stakeholder i and SBU for strategy t; ID(i, t): interdependence between stakeholder i and SBU for strategy t; CP (i, t): cooperation value between stakeholder i and SBU for strategy t; CF (i, t): conflict value between stakeholder i and SBU for strategy t; n: total numbers of key stakeholders; w cp , w cf : weighting factors (w cp + w cf = 1).
The weights like w cp and w cf can be determined as perceived by managers. A more palatable alternative would be the use of the industry wide survey. that the current strategy is better and continue to employ it. Otherwise, they can choose the alternative whose SRII is greater. In our case, it is found that the second strategic alternative is better. Appendix 5 illustrates how this decision is made.
Strategy Implementation
This phase makes a detailed action plan, implements it, and gathers feedback for its new strategy. For making the action plan, the gap between the current capability and that of enacting a new strategy is analyzed. 13 Because of this gap, detailed action plans are prepared with appropriate milestones. This action plan in medical EDI business is depicted in Appendix 6. Clearly, corporations need to monitor the financial results according to the new strategy. If the results are not satisfactory, it is desirable to formulate the business strategy again. The actual strategy adopted by medical EDI business is shown in Table 4 . Comparing this actual strategy with Alternatives 1 and 2, Alternative 2 is more similar in that medical S/W firms are major joint marketing partners. Interestingly, despite being secondary stakeholders, medical S/W firms were shown to be the key stakeholders for the success of this business. This similarity confirms that our proposed methodology is suitable for formulating business strategy for medical EDI business in 2000.
Discussion
Here, we highlight the business results of three cases adopted by our methodology. Table 5 summarizes BFP results during the 3 years after adopting new strategies.
In the first case, it is noted that the medical EDI business has reaped much benefit from adopting new strategies. The year 2000 was the turning point for positive ROS. In 2002, sales volume increased four times compared with that in 1999. Therefore, it would appear that the actual strategy from our methodology is satisfactory. Strategy managers tend to believe that the challenges to formulate better strategies are responded well. For the second case, it is noted that the electronic prescription has extended to about 35 hospitals. F Corporation market share increased over 80%. Furthermore, the result in the tax receipt for cash business case shows a rather surprising result. All of the medical S/W firms except for hospitals collaborated with F Corporation and their market ratio was found to be over 90%. Therefore, F Corporation would be able to extend the service area to most medical institutions via the medical S/W firms. In sum, our methodology is likely to produce more robust strategies.
Comparison of Methodologies
Methodologies for formulating business strategies may be compared as shown in Table 6 . Comparison criteria include strategic focus, analysis method, key factors, performance variable, application area, strength, and case. Our methodology differs as follows.
First, our methodology focuses on the external environment of SBU such as stakeholder demands and relationships. By contrast, Grant's 12 methodology emphasized the corporate internal resources and capabilities. Currently, our perspective is more widely accepted because understanding the external environment is likely to offer an immense opportunity. Second, past methodologies gave little research for comparing strategies in a systemic fashion. We introduce the concept of stakeholder's relationship improvement for this comparison (e.g. SRII). Improving the relationship between business organization and stakeholders may create a ladder of 
Conclusion
The implementation of great strategies is an art. Yet, the description of strategies can be a science. Helping people describe strategies in a more disciplined way will increase the likelihood of their successful implementation. 16 For this purpose, this paper proposes a methodology for formulating business strategies from a stakeholders' perspective. A business tends to have strong attachments for its stakeholders. They represent an important component of a corporate identity. Our methodology can help business leaders recognize the significance of the stakeholders' influence on their businesses, make practical use of stakeholders' heterogeneous demands, and find a better business strategy in financial and ethical aspects. Our methodology has the following unique features. First, it is particularly useful for businesses having complicated and conflicting stakeholders. Second, formulating business strategies begins with stakeholders' demands. Third, business social performance is employed for evaluating strategies. The following future research may sharpen our current study. First, applying our methodology to other industry sectors may be of interest. By applying the lessons from these experiences, our methodology will be able to make the transition to a more systematic approach. Second, estimating stakeholders' variables is arguably one of the most difficult tasks. Fending off these difficulties must be at the top of every strategic manager's agenda. Building a decision support system with related knowledge repository may relieve these difficulties. We are in the process of implementing this system by employing CBR (case-based reasoning) technique and will report the result in the near future.
Appendix 1: Electronic prescription business (F Corporation) and tax receipt for cash business (K Corporation)
A case for electronic prescription business in F Corporation: Electronic prescription service enables the electronic delivery of prescription from medical doctor to pharmacist through the internet. In Korea, this service can be practical due to the enforcement of the rule on the separation of medical practices and drug dispensation in July 2000 and the widespread use of ADSL in hospitals and pharmacies. This service provide several merits; (i) no need to re-enter the prescription contents in pharmacy for medical claims, (ii) reduction in the patient's waiting time during compounding of medicine in pharmacy, and (iii) reduction in the number of prescription copies. F Corporation was founded for this business. Although this business had good prospect in the future, it had several critical strategic problems due to complicated stakeholders' conflicts (government, hospitals, pharmacies, pharmacy association groups, patients). Major significant conflicts among stakeholders can be illustrated by the service charge between hospitals and pharmacies, the delivery method of electronic prescription among pharmacies, the illegal collusion between hospital and pharmacy, and the government's penalty for unfair transaction among pharmacies.
In order to make this business successful, F Corporation is confronted with strategic problems: (i) the lack of balance in the management of stakeholders, (ii) the subject of service charge, and (iii) the resolution of conflicting stakeholders.
A case of tax receipt for cash business in K Corporation: In Korea, the government enacts the law of tax receipt for cash; the receipt with a tax acknowledgement number is issued to the cash transaction over 5,000 Won from the beginning of year 2005. The purpose of this law is to have transparent cash transaction to the retailers and independent businesses; it is similar to the law of tax receipt for credit card enacted several years ago. Deduction of the earned income tax to the amount of credit card transaction has resulted in the surprising increase in credit card transactions. Despite the increases in VAT (value-added tax) and income tax, the excessive transactions of credit cards have resulted in the bankruptcy of about 3 million people and caused serious social problems. Therefore, the government enacts the law of tax receipt for cash. To activate this law, the Tax Administration Agency raised the execution corporation of tax receipt (ECTR) for cash business which is to install issuing receipt systems in the shops of retailers and independent businesses.
Although it has business experience in the medical field, K Corporation is confronted with strategic problems due to complicated stakeholders (government, hospitals, clinics, pharmacies, hospital agency groups, medical association groups, pharmaceutical association groups, patients). First, the organizational resistance to this law enlarges in medical institutions. Although government has enforced the law through the bill receipt of medical treatment several years ago, only the hospitals actively participated because the deduction rate to the small amount of money in clinics and pharmacies is small. Second, the competition of this service among ECTRs in the medical field is probably intense. Most medical institutions and pharmacies already installed the device for credit card via VAN (value-added network) corporations using telephone network. This device can be used for ECTR service with easy maintenance and competition with VAN corporations is inevitable. Third, the implementation of this law enforcement in medical institutions and pharmacies is not ready because of the shortage of exclusive printers for this service.
In summary, several strategic problems are noted: (i) the lack of balance in the management of stakeholders, (ii) the lack of counterplan to the competing enterprises, and (iii) insufficient business circumstances. 
